NCT06142747 Tracking of Red Blood Cells Using Super Resolution Ultrasound in Persons With Healthy or Overuse Injured Tendons
| NCT ID | NCT06142747 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Bispebjerg and Frederiksberg |
| Condition | Tendinopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 135 participants |
| Start Date | 2024-02-08 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 135 participants in total. It began in 2024-02-08 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to test whether a new ultrasound method, called SUper Resolution ultrasound imaging of Erythrocytes (SURE), can image the small blood vessels found in tendons of persons with a tendon overuse injury (tendinopathy). The main questions it aims to answer are: * Is the method sensitive enough to detect the smallest blood vessels * What information about the blood flow can be obtained (flow velocity, pressure, shape of the vessels) * Can the flow in an injured tendon be distinguished from that of a healthy one Participants will receive a non-invasive ultrasound examination of their Achilles (heel) or patellar (knee) tendon, using an advanced high frequency research ultrasound system. Researchers will compare participants with either an Achilles or patellar tendon overuse injury to participants with healthy tendons, to see if there are distinct differences in the blood vessels that could help diagnose and treat the injuries.
Eligibility Criteria
Inclusion Criteria: * 18 to 70 years of age. * BMI below 30. * Able to lie still for 1 minute. * Capable of providing signed informed consent. Exclusion Criteria: * Pregnancy. * Dementia. * Smoking. * Diabetes. * Arthritis. * Current or historical injuries to the tendon or surrounding tissue aside from tendinopathy. * Medical or surgical treatments for their tendinopathy that may influence blood flow.
Contact & Investigator
Michael Kjaer, PhD
STUDY DIRECTOR
University Hospital Bispebjerg and Frederiksberg
Frequently Asked Questions
Who can join the NCT06142747 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Tendinopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06142747 currently recruiting?
Yes, NCT06142747 is actively recruiting participants. Contact the research team at rene.brueggebusch.svensson@regionh.dk for enrollment information.
Where is the NCT06142747 trial being conducted?
This trial is being conducted at Copenhagen, Denmark.
Who is sponsoring the NCT06142747 clinical trial?
NCT06142747 is sponsored by University Hospital Bispebjerg and Frederiksberg. The principal investigator is Michael Kjaer, PhD at University Hospital Bispebjerg and Frederiksberg. The trial plans to enroll 135 participants.